Baseline prevalence of CKD by category of 24-h UOx overall and among patients with a malabsorptive condition.
| . | 24-h urine oxalate (mg/24 h) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| . | <20 . | 20–29 . | 30–39 . | 40–44 . | 45–49 . | 50–59 . | 60–69 . | 70–79 . | 80+ mg . |
| All patients, n | 35 246 | 136 608 | 137 148 | 45 040 | 31 216 | 33 868 | 14 766 | 6863 | 7203 |
| Baseline CKD, n (%) | 1395 (4.0) | 5813 (4.3) | 6294 (4.6) | 2229 (4.9) | 1586 (5.1) | 1775 (5.2) | 905 (6.1) | 472 (6.9) | 593 (8.2) |
| Patients with a malabsorptive condition, n | 991 | 3320 | 3265 | 1102 | 902 | 1154 | 684 | 437 | 667 |
| Baseline CKD, n (%) | 72 (7.3) | 286 (8.6) | 295 (9.0) | 105 (9.5) | 116 (12.9) | 139 (12.0) | 91 (13.3) | 65 (14.9) | 114 (17.1) |
| . | 24-h urine oxalate (mg/24 h) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| . | <20 . | 20–29 . | 30–39 . | 40–44 . | 45–49 . | 50–59 . | 60–69 . | 70–79 . | 80+ mg . |
| All patients, n | 35 246 | 136 608 | 137 148 | 45 040 | 31 216 | 33 868 | 14 766 | 6863 | 7203 |
| Baseline CKD, n (%) | 1395 (4.0) | 5813 (4.3) | 6294 (4.6) | 2229 (4.9) | 1586 (5.1) | 1775 (5.2) | 905 (6.1) | 472 (6.9) | 593 (8.2) |
| Patients with a malabsorptive condition, n | 991 | 3320 | 3265 | 1102 | 902 | 1154 | 684 | 437 | 667 |
| Baseline CKD, n (%) | 72 (7.3) | 286 (8.6) | 295 (9.0) | 105 (9.5) | 116 (12.9) | 139 (12.0) | 91 (13.3) | 65 (14.9) | 114 (17.1) |
Baseline prevalence of CKD by category of 24-h UOx overall and among patients with a malabsorptive condition.
| . | 24-h urine oxalate (mg/24 h) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| . | <20 . | 20–29 . | 30–39 . | 40–44 . | 45–49 . | 50–59 . | 60–69 . | 70–79 . | 80+ mg . |
| All patients, n | 35 246 | 136 608 | 137 148 | 45 040 | 31 216 | 33 868 | 14 766 | 6863 | 7203 |
| Baseline CKD, n (%) | 1395 (4.0) | 5813 (4.3) | 6294 (4.6) | 2229 (4.9) | 1586 (5.1) | 1775 (5.2) | 905 (6.1) | 472 (6.9) | 593 (8.2) |
| Patients with a malabsorptive condition, n | 991 | 3320 | 3265 | 1102 | 902 | 1154 | 684 | 437 | 667 |
| Baseline CKD, n (%) | 72 (7.3) | 286 (8.6) | 295 (9.0) | 105 (9.5) | 116 (12.9) | 139 (12.0) | 91 (13.3) | 65 (14.9) | 114 (17.1) |
| . | 24-h urine oxalate (mg/24 h) . | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| . | <20 . | 20–29 . | 30–39 . | 40–44 . | 45–49 . | 50–59 . | 60–69 . | 70–79 . | 80+ mg . |
| All patients, n | 35 246 | 136 608 | 137 148 | 45 040 | 31 216 | 33 868 | 14 766 | 6863 | 7203 |
| Baseline CKD, n (%) | 1395 (4.0) | 5813 (4.3) | 6294 (4.6) | 2229 (4.9) | 1586 (5.1) | 1775 (5.2) | 905 (6.1) | 472 (6.9) | 593 (8.2) |
| Patients with a malabsorptive condition, n | 991 | 3320 | 3265 | 1102 | 902 | 1154 | 684 | 437 | 667 |
| Baseline CKD, n (%) | 72 (7.3) | 286 (8.6) | 295 (9.0) | 105 (9.5) | 116 (12.9) | 139 (12.0) | 91 (13.3) | 65 (14.9) | 114 (17.1) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
